Hepatic Stellate Cells Transmigration and Remodeling Are Related to CCN3 in Oxaliplatin-Resistant Hepatocellular Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.24244
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3

OncoTargets and Therapy
OncologyPharmacology
2020English

Activated Hepatic Stellate Cells Promote Hepatocellular Carcinoma Cell Migration and Invasion via the Activation of FAK-MMP9 Signaling

Oncology Reports
MedicineCancer ResearchOncology
2013English

CCN3 Is a Therapeutic Target Relating Enhanced Stemness and Coagulation in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2017English

Soluble FGL2, a Novel Effector Molecule of Activated Hepatic Stellate Cells, Regulates T-Cell Function in Cirrhotic Patients With Hepatocellular Carcinoma

Hepatology International
Hepatology
2014English

Hepatic Stellate Cells and Alcoholic Liver Disease

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2006English

Clusterin Role in Hepatocellular Carcinoma Patients Treated With Oxaliplatin

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Hepatic Stellate Cells: Central Modulators of Hepatic Carcinogenesis

BMC Gastroenterology
MedicineGastroenterology
2015English

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells

Genes
Genetics
2018English

Targeted Delivery of siRNA to Hepatocytes and Hepatic Stellate Cells by Bioconjugation

Bioconjugate Chemistry
Organic ChemistryBiotechnologyPharmacologyPharmaceutical ScienceBioengineeringBiomedical Engineering
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy